PAUL F TRUEX Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL F TRUEX.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL F TRUEX. PAUL F TRUEX is Director in CymaBay Therapeutics, Inc. ($CBAY) and in Anthera Pharmaceuticals Inc ($ANTH) and Chief Executive Officer in Anthera Pharmaceuticals Inc ($ANTH) and Executive Chaiman in Anthera Pharmaceuticals Inc ($ANTH) and Executive Chairman in Anthera Pharmaceuticals Inc ($ANTH) and President and CEO in Anthera Pharmaceuticals Inc ($ANTH) and Director in Milestone Pharmaceuticals Inc. ($MIST).
Latest Insider Trading Transactions of PAUL F TRUEX
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANTH, CBAY, MIST
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 28 2021 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 5.78 | 32,000 | 184,960 | 32,000 | |
Jun 08 2020 | MIST | Milestone Pharmace ... | TRUEX PAUL F | Director | Option Exercise | A | 3.74 | 15,000 | 56,100 | 15,000 | |
May 19 2020 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 4.05 | 49,245 | 199,442 | 49,245 | |
Nov 14 2019 | MIST | Milestone Pharmace ... | TRUEX PAUL F | Director | Option Exercise | A | 17.78 | 4,000 | 71,120 | 4,000 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 8.43 | 27,705 | 233,553 | 27,705 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Sep 26 2017 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 7.47 | 7,500 | 56,025 | 7,500 | |
Sep 07 2017 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Buy | P | 1.34 | 5,000 | 6,700 | 16,793 | 11.8 K to 16.8 K (+42.40 %) | |
Jun 30 2017 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 5.50 | 15,000 | 82,500 | 15,000 | |
May 19 2017 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Executive Chaiman | Option Exercise | J | 39.04 | 84,376 | 3,294,039 | 0 | |
May 19 2017 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Executive Chaiman | Option Exercise | J | 96.64 | 1,369 | 132,300 | 0 | |
Jan 23 2017 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 1.72 | 12,000 | 20,640 | 12,000 | |
Dec 06 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Executive Chairman | Option Exercise | J | 9.48 | 180,000 | 1,706,400 | 0 | |
Dec 06 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Executive Chairman | Option Exercise | J | 9.48 | 170,000 | 1,611,600 | 0 | |
Sep 22 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Chief Executive Off ... | Option Exercise | M | 2.08 | 5,008 | 10,417 | 25,845 | |
Sep 22 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Chief Executive Off ... | Gift | G | 0.00 | 5,008 | 0 | 94,345 | 89.3 K to 94.3 K (+5.61 %) |
Sep 22 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Chief Executive Off ... | Gift | G | 0.00 | 5,008 | 0 | 0 | 5 K to 0 (-100.00 %) |
Sep 22 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Chief Executive Off ... | Buy | M | 2.08 | 5,008 | 10,417 | 5,008 | 0 to 5 K |
Jun 13 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Chief Executive Off ... | Option Exercise | A | 3.52 | 300,000 | 1,056,000 | 300,000 | |
Apr 28 2016 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 2.81 | 18,000 | 50,580 | 18,000 | |
Feb 16 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Chief Executive Off ... | Option Exercise | A | 2.86 | 15,816 | 45,234 | 15,816 | |
Sep 18 2015 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | A | 9.48 | 180,000 | 1,706,400 | 180,000 | |
Sep 18 2015 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | A | 9.48 | 170,000 | 1,611,600 | 170,000 | |
Aug 09 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | M | 0.26 | 50,000 | 13,000 | 282,826 | |
Aug 09 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Buy | M | 0.26 | 50,000 | 13,000 | 90,512 | 40.5 K to 90.5 K (+123.42 %) |
Jul 18 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Sell | S | 7.95 | 15,000 | 119,258 | 667,125 | 682.1 K to 667.1 K (-2.20 %) |
Jul 05 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Payment of Exercise | F | 8.17 | 48,500 | 396,245 | 40,512 | 89 K to 40.5 K (-54.49 %) |
Jun 17 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Sell | S | 8.30 | 15,000 | 124,539 | 682,125 | 697.1 K to 682.1 K (-2.15 %) |
Jun 17 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 5,122 | 0 | 697,125 | 692 K to 697.1 K (+0.74 %) |
Jun 17 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 5,122 | 0 | 86,000 | 91.1 K to 86 K (-5.62 %) |
May 18 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Sell | S | 7.16 | 15,000 | 107,339 | 692,003 | 707 K to 692 K (-2.12 %) |
May 18 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 9,000 | 0 | 707,003 | 716 K to 707 K (-1.26 %) |
May 18 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 30,000 | 0 | 716,003 | 686 K to 716 K (+4.37 %) |
May 18 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 30,000 | 0 | 91,122 | 121.1 K to 91.1 K (-24.77 %) |
Apr 14 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | M | 0.26 | 30,000 | 7,800 | 332,826 | |
Apr 14 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Buy | M | 0.26 | 30,000 | 7,800 | 121,122 | 91.1 K to 121.1 K (+32.92 %) |
Apr 14 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 7,250 | 0 | 686,003 | 693.3 K to 686 K (-1.05 %) |
Apr 14 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 693,253 | 0 | 693,253 | 0 to 693.3 K |
Apr 14 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 693,253 | 0 | 91,122 | 784.4 K to 91.1 K (-88.38 %) |
Jan 04 2011 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | A | 4.88 | 260,000 | 1,268,800 | 260,000 | |
Jul 14 2010 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 23,364 | 0 | 779,253 | 802.6 K to 779.3 K (-2.91 %) |
Jul 02 2010 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Grant | A | 0.00 | 50,000 | 0 | 802,617 | 752.6 K to 802.6 K (+6.64 %) |
Jul 02 2010 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Grant | A | 0.00 | 36,000 | 0 | 752,617 | 716.6 K to 752.6 K (+5.02 %) |
Apr 07 2010 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | M | 0.14 | 23,364 | 3,271 | 0 | |
Apr 07 2010 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Buy | M | 0.14 | 23,364 | 3,271 | 716,617 | 693.3 K to 716.6 K (+3.37 %) |
Mar 05 2010 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | C | 0.00 | 8,567 | 0 | 0 | |
Mar 05 2010 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | C | 0.00 | 20,719 | 0 | 0 | |
Mar 05 2010 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Buy | C | 0.00 | 8,567 | 0 | 693,253 | 684.7 K to 693.3 K (+1.25 %) |
Mar 05 2010 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Buy | C | 0.00 | 20,719 | 0 | 684,686 | 664 K to 684.7 K (+3.12 %) |
Mar 02 2010 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Buy | P | 7.05 | 500 | 3,525 | 663,967 | 663.5 K to 664 K (+0.08 %) |
Mar 02 2010 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Buy | P | 7.19 | 200 | 1,438 | 663,467 | 663.3 K to 663.5 K (+0.03 %) |
Mar 02 2010 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Buy | P | 7.18 | 300 | 2,154 | 663,267 | 663 K to 663.3 K (+0.05 %) |
Page: 1